Net Cash Provided by (Used in) Operating Activities |
21.5 M |
USD |
+10.2% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-271 M |
USD |
-238% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
287 M |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
500 M |
shares |
0% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
139 M |
shares |
-0.94% |
Q1 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
36.9 M |
USD |
-68.7% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
252 M |
USD |
-46% |
Q1 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
117 M |
USD |
+13.5% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
25.5 M |
USD |
+27.5% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Gross |
21.7 M |
USD |
+30.7% |
Q4 2023 |
FY 2023 |
Depreciation |
9.2 M |
USD |
+12.7% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
17.8 M |
USD |
+21.1% |
Q4 2023 |
FY 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Additional Paid in Capital |
2.73 B |
USD |
+0.51% |
Q1 2024 |
Q1 2024 |
Share-based Payment Arrangement, Expense |
0 |
USD |
|
Q1 2022 |
Q1 2023 |
Interest Expense |
480 M |
USD |
+54.6% |
Q1 2024 |
Q1 2024 |